{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T19:19:44Z","timestamp":1770664784272,"version":"3.49.0"},"publisher-location":"Dordrecht","reference-count":21,"publisher":"Springer Netherlands","isbn-type":[{"value":"9789400766266","type":"print"},{"value":"9789400766273","type":"electronic"}],"license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-94-007-6627-3_19","type":"book-chapter","created":{"date-parts":[[2013,7,8]],"date-time":"2013-07-08T09:16:00Z","timestamp":1373274960000},"page":"125-132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["In Vitro Susceptibility of Staphylococci and Enterococci to Vancomycin and Teicoplanin"],"prefix":"10.1007","author":[{"given":"A.","family":"Guzek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Korzeniewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aneta","family":"Nitsch-Osuch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Rybicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Prokop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,30]]},"reference":[{"key":"19_CR00191","first-page":"816","volume":"19","author":"Y Cetinkaya","year":"2000","unstructured":"Cetinkaya, Y., Falk, P., & Mayhall, C. (2000). Vancomycin-resistant enterococci. Clinical Microbiology Reviews, 19, 816\u2013822.","journal-title":"Clinical Microbiology Reviews"},{"key":"19_CR00192","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1086\/491711","volume":"42","author":"P Courvalin","year":"2006","unstructured":"Courvalin, P. (2006). Vancomycin resistance in gram-positive cocci. Clinical Infectious Diseases, 42, S25\u2013S34.","journal-title":"Clinical Infectious Diseases"},{"key":"19_CR00193","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1128\/JCM.41.1.5-14.2003","volume":"41","author":"L Cui","year":"2003","unstructured":"Cui, L., Ma, K., Sato, M., Okuma, K., Tenover, F. C., Mamizuka, E. M., Gemmell, C. G., Kim, M. N., Ploy, M. C., El-Solh, N., Ferraz, V., & Hiramatsu, K. (2003). Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. Journal of Clinical Microbiology, 41, 5\u201314.","journal-title":"Journal of Clinical Microbiology"},{"key":"19_CR00194","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1128\/AAC.50.2.428-438.2006","volume":"50","author":"L Cui","year":"2006","unstructured":"Cui, L., Iwamoto, J., Neoh, H., Mruyama, T., Horikawa, Y., & Hiramatsu, K. (2006). Novel mechanisms of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus. Antimicrobial Agents Chemotherapy, 50, 428\u2013438.","journal-title":"Antimicrobial Agents Chemotherapy"},{"key":"19_CR00195","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1471-2334-12-104","volume":"12","author":"R Hall","year":"2012","unstructured":"Hall, R., Giuliano, C., Haase, K., Hazelwood, K., Frei, C., Forcade, N., Brouse, S., Bell, T., Bedimo, R., & Alvarez, C. (2012). Empiric guide-line-recommended weight-based vancomycin dosing and mortality in methicillin-resistant Staphylococcus aureus bacteraemia: A retrospective cohort study. BMC Infectious Diseases, 12, 104\u2013124.","journal-title":"BMC Infectious Diseases"},{"key":"19_CR00196","first-page":"1","volume-title":"Contemporary views on resistance of bacteria to antibiotics. Infections in intensive care \u2013 the place and role of antibiotics","year":"2000","unstructured":"Hryniewicz, W. (Ed.). (2000). Contemporary views on resistance of bacteria to antibiotics. Infections in intensive care \u2013 the place and role of antibiotics (pp. 1\u201315). Wroclaw: Urban & Partner (in Polish)."},{"key":"19_CR00197","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1086\/342708","volume":"186","author":"F Hussain","year":"2002","unstructured":"Hussain, F., Boyle-Vavra, P., Shete, B., & Daum, R. (2002). Evidence for continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates. Journal of Infectious Diseases, 186, 661\u2013667.","journal-title":"Journal of Infectious Diseases"},{"key":"19_CR00198","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.mimet.2008.09.017","volume":"76","author":"A Jain","year":"2009","unstructured":"Jain, A., & Agarwal, A. (2009). Biofilm production, a marker of pathogenic potential of colonizing and commensal staphylococci. Journal of Microbiological Methods, 76, 88\u201392.","journal-title":"Journal of Microbiological Methods"},{"issue":"Suppl 1","key":"19_CR00199","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1086\/653053","volume":"51","author":"R Jones","year":"2010","unstructured":"Jones, R. N. (2010). Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clinical Infectious Diseases, 51(Suppl 1), S81\u2013S87.","journal-title":"Clinical Infectious Diseases"},{"key":"19_CR001910","first-page":"2102","volume":"31","author":"C Joukhadar","year":"2001","unstructured":"Joukhadar, C. (2001). Impaired target site penetration of b-lactams may account for therapeutic failure in patients with septic shock. Critical Care Medicine, 31, 2102\u20132109.","journal-title":"Critical Care Medicine"},{"key":"19_CR001911","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1097\/CCM.0b013e3181eb3b96","volume":"38","author":"AC Kalil","year":"2010","unstructured":"Kalil, A. C., Murthy, M. H., Hermsen, E. D., Neto, F. K., Sun, J., & Rupp, M. E. (2010). Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: A systematic review and meta-analysis. Critical Care Medicine, 38, 1802\u20131808.","journal-title":"Critical Care Medicine"},{"key":"19_CR001912","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1128\/AAC.00113-08","volume":"52","author":"T Lodise","year":"2008","unstructured":"Lodise, T., Grawes, A., Evans, A., Graffunder, E., Helmecke, M., Lomaestro, B., & Stellrecht, K. (2008). Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrobial Agents and Chemotherapy, 52, 3315\u20133320.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"19_CR001913","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1099\/jmm.0.034066-0","volume":"60","author":"X Ma","year":"2011","unstructured":"Ma, X., Wang, E., Liu, Y., & Luo, E. (2011). Antibiotic susceptibility of coagulase-negative staphylococci (CoNS): Emergence of teicoplanin-non-susceptible CoNS strains with inducible resistance to vancomycin. Journal of Medical Microbiology, 60, 1661\u20131668.","journal-title":"Journal of Medical Microbiology"},{"key":"19_CR001914","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00134-006-0136-3","volume":"32","author":"O Mimoz","year":"2006","unstructured":"Mimoz, O., Rolland, D., Adoun, M., Marchand, S., Breilh, D., Brumpt, I., Debaene, B., & Couet, W. (2006). Steady-state trough serum and epithelial lining fluid concentrations of teicoplanin 12\u00a0mg\/kg per day in patients with ventilator-associated pneumonia. Intensive Care Medicine, 32, 775\u2013779.","journal-title":"Intensive Care Medicine"},{"issue":"3","key":"19_CR001915","first-page":"237","volume":"35","author":"G Nimmo","year":"2011","unstructured":"Nimmo, G., Pearson, J., Collignon, P., Christiansen, K., Coombs, G., Bell, J., & McLaws, M. (2011). Australian group on antimicrobial resistance. Communicable Diseases Intelligence, 35(3), 237\u2013243.","journal-title":"Communicable Diseases Intelligence"},{"key":"19_CR001916","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.vetmic.2008.09.009","volume":"134","author":"A Piette","year":"2009","unstructured":"Piette, A., & Verschragen, G. (2009). Role of coagulase-negative staphylococci in human disease. Veterinary Microbiology, 134, 45\u201354.","journal-title":"Veterinary Microbiology"},{"issue":"1","key":"19_CR001917","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1128\/JCM.00914-10","volume":"49","author":"A Pitz","year":"2011","unstructured":"Pitz, A., Yu, E., Hermsen, E., Rupp, M., Fey, P., & Olsen, M. (2011). Vancomycin susceptibility and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates. Journal of Clinical Microbiology, 49(1), 269\u2013274.","journal-title":"Journal of Clinical Microbiology"},{"key":"19_CR001918","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1128\/JCM.00582-08","volume":"46","author":"M Rybak","year":"2008","unstructured":"Rybak, M., Leonard, S., Rosii, C., Cheung, C., Sader, H., & Jones, R. (2008). Characterization of vancomycin-hetero resistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007). Journal of Clinical Microbiology, 46, 2950\u20132954.","journal-title":"Journal of Clinical Microbiology"},{"key":"19_CR001919","first-page":"166","volume":"3","author":"P Smuszkiewicz","year":"2007","unstructured":"Smuszkiewicz, P., Szalek, E., Tomczak, H., Trojanowska, I., & B\u0142aszyk, M. (2007). Pharmacokinetic and pharmacodynamic use of antibiotics in patients treated for sepsis. Anaesthesiology Intensive Therapy, 3, 166\u2013174 (in Polish).","journal-title":"Anaesthesiology Intensive Therapy"},{"key":"19_CR001920","first-page":"1","volume":"5","author":"C Thierfelder","year":"2012","unstructured":"Thierfelder, C., Keller, P., Kocher, C., Gaudenz, R., Hombach, M., Bloemberg, G., & Ruef, C. (2012). Vancomycin-resistant Enterococcus. A multi-strain outbreak of eight weeks duration at a Swiss tertiary care hospital. Swiss Medical Weekly, 5, 1\u20136.","journal-title":"Swiss Medical Weekly"},{"key":"19_CR001921","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1086\/421946","volume":"39","author":"H Wisplinghof","year":"2004","unstructured":"Wisplinghof, H., Bischoff, T., Tallent, S., Seifert, H., Wenzel, R., & Edmond, M. (2004). Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective national wide surveillance study. Clinical Infectious Diseases, 39, 309\u2013317.","journal-title":"Clinical Infectious Diseases"}],"container-title":["Advances in Experimental Medicine and Biology","Neurobiology of Respiration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-94-007-6627-3_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T13:48:28Z","timestamp":1676814508000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-94-007-6627-3_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"ISBN":["9789400766266","9789400766273"],"references-count":21,"URL":"https:\/\/doi.org\/10.1007\/978-94-007-6627-3_19","relation":{},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"30 May 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}